+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
27687-14-5,MFCD00673773
Catalog No.:AA002UDX

27687-14-5 | Boc-tranexamic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$7.00   $5.00
- +
5g
97%
in stock  
$29.00   $20.00
- +
10g
97%
in stock  
$34.00   $24.00
- +
25g
97%
in stock  
$75.00   $53.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA002UDX
Chemical Name:
Boc-tranexamic acid
CAS Number:
27687-14-5
Molecular Formula:
C13H23NO4
Molecular Weight:
257.3260
MDL Number:
MFCD00673773
SMILES:
O=C(OC(C)(C)C)NC[C@@H]1CC[C@H](CC1)C(=O)O
Properties
Properties
 
BP:
410 °C at 760 mmHg  
Form:
Solid  
MP:
133.0 to 137.0 °C  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
301  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.9  

Downstream Synthesis Route

[1]JournalofMedicinalChemistry,1986,vol.29,p.448-453

[1]CurrentPatentAssignee:GPCRTHERAPEUTICSINC-US2016/90394,2016,A1Locationinpatent:Paragraph0029;0030

[2]Brennauer,Albert;Keller,Max;Freund,Matthias;Bernhardt,Günther;Buschauer,Armin[TetrahedronLetters,2007,vol.48,#39,p.6996-6999]

[3]Svahn;Merenyi;Karlson;Widlund;Graells[JournalofMedicinalChemistry,1986,vol.29,#4,p.448-453]

[4]CurrentPatentAssignee:HINOVAPHARMACEUTICALS-EP3971176,2022,A1Locationinpatent:Paragraph0404-0405

[5]CurrentPatentAssignee:HINOVAPHARMACEUTICALS-EP3971176,2022,A1Locationinpatent:Paragraph0404-0405

[6]CurrentPatentAssignee:HINOVAPHARMACEUTICALS-EP3971176,2022,A1Locationinpatent:Paragraph0404-0405

[7]CurrentPatentAssignee:RESONACHOLDINGSCORPORATION-US5166403,1992,A

[8]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-EP727211,1996,A1

[9]Burns,DavidJ.;Lee,Ai-Lan;McLean,EuanB.;Mooney,DavidT.[OrganicLetters,2022,vol.24,#2,p.686-691]

[10]Kanuma,Kosuke;Omodera,Katsunori;Nishiguchi,Mariko;Funakoshi,Takeo;Chaki,Shigeyuki;Semple,Graeme;Tran,Thuy-Anh;Kramer,Bryan;Hsu,Debbie;Casper,Martin;Thomsen,Bill;Beeley,Nigel;Sekiguchi,Yoshinori[BioorganicandMedicinalChemistryLetters,2005,vol.15,#10,p.2565-2569]

[11]CurrentPatentAssignee:H.LUNDBECKA/S-US2007/213376,2007,A1Locationinpatent:Page/Pagecolumn10

[12]CurrentPatentAssignee:THEUNIVERSITYOFHONGKONG-WO2020/103891,2020,A1Locationinpatent:Page/Pagecolumn29;32-35

[13]Joossens;VanDerVeken;Lambeir;Augustyns;Haemers[JournalofMedicinalChemistry,2004,vol.47,#10,p.2411-2413]

[14]CurrentPatentAssignee:ASTRAZENECAPLC-US5914319,1999,A

[15]CurrentPatentAssignee:ASTRAZENECAPLC-US5705487,1998,A

[16]CurrentPatentAssignee:ASTRAZENECAPLC-US5710130,1998,A

[17]CurrentPatentAssignee:ASTRAZENECAPLC-US5707966,1998,A

[18]CurrentPatentAssignee:ASTRAZENECAPLC-US5726159,1998,A

[19]CurrentPatentAssignee:GPCRTHERAPEUTICSINC-US2006/281712,2006,A1Locationinpatent:Page/Pagecolumn122-124

[20]Jin,Fangfang;Hu,Qiyue;Fei,Hongbo;Lv,Hejun;Wang,Shenglan;Gui,Bin;Zhang,Junzhen;Tu,Wangyang;Zhang,Yun;Zhang,Lei;Wan,Hong;Zhang,Limin;Hu,Bin;Yang,Fanglong;Bai,Chang;He,Feng;Zhang,Lianshan;Tao,Weikang[ACSMedicinalChemistryLetters,2021,vol.12,#2,p.195-201]

[21]CurrentPatentAssignee:KUREHACORP.-EP1273571,2003,A1

[22]CurrentPatentAssignee:JIANGSUYANGNONGCHEMICALCO.,LTD.-CN114736168,2022,ALocationinpatent:Paragraph0101-0104

[23]CurrentPatentAssignee:ALTOSLABSINC-WO2022/212902,2022,A1Locationinpatent:Paragraph0335

[24]CurrentPatentAssignee:ALTOSLABSINC-WO2022/212902,2022,A1Locationinpatent:Paragraph0335

27687-14-5    50893-36-2   
4-(tert-Butoxycarbonylamino-methyl)-cyclohexanecarboxylicacid1-ethoxycarbonyloxy-ethylester 

[1]JournalofMedicinalChemistry,1986,vol.29,p.448-453

27687-14-5    98298-66-9   
4-(tert-Butoxycarbonylamino-methyl)-cyclohexanecarboxylicacid1-isopropoxycarbonyloxy-ethylester 

[1]JournalofMedicinalChemistry,1986,vol.29,p.448-453

[1]Li,Liantao;Mayer,Matthias;Schneider,Erich;Schreiber,Elvira;Bernhardt,Guenther;Peng,Shiqi;Buschauer,Armin[ArchivderPharmazie,2003,vol.336,#12,p.585-590]

[2]CurrentPatentAssignee:GPCRTHERAPEUTICS-US2016/90394,2016,A1Locationinpatent:Paragraph0029;0031

[3]CurrentPatentAssignee:TESPHARMA-WO2020/104456,2020,A1Locationinpatent:Paragraph00546

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 27687-14-5
1000933-99-2

1000933-99-2

 1008773-73-6

1008773-73-6

 1021919-45-8

1021919-45-8

 1160247-17-5

1160247-17-5

 115951-16-1

115951-16-1

 1250996-75-8

1250996-75-8
Building Blocks
More >
Historical Records
898344-67-7

898344-67-7
Tags:27687-14-5 Molecular Formula|27687-14-5 MDL|27687-14-5 SMILES|27687-14-5 Boc-tranexamic acid
Catalog No.: AA002UDX
27687-14-5,MFCD00673773
27687-14-5 | Boc-tranexamic acid
Pack Size： 1g
Purity： 97%
in stock
$7.00 $5.00
Pack Size： 5g
Purity： 97%
in stock
$29.00 $20.00
Pack Size： 10g
Purity： 97%
in stock
$34.00 $24.00
Pack Size： 25g
Purity： 97%
in stock
$75.00 $53.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA002UDX
Chemical Name: Boc-tranexamic acid
CAS Number: 27687-14-5
Molecular Formula: C13H23NO4
Molecular Weight: 257.3260
MDL Number: MFCD00673773
SMILES: O=C(OC(C)(C)C)NC[C@@H]1CC[C@H](CC1)C(=O)O
Properties
BP: 410 °C at 760 mmHg  
Form: Solid  
MP: 133.0 to 137.0 °C  
Storage: Keep in dry area;Room Temperature;  
Complexity: 301  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 5  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.9  
Downstream Synthesis Route
61644-18-6    27687-14-5    87589-31-9 

[1]JournalofMedicinalChemistry,1986,vol.29,p.448-453

24424-99-5    1197-18-8    27687-14-5 

[1]CurrentPatentAssignee:GPCRTHERAPEUTICSINC-US2016/90394,2016,A1Locationinpatent:Paragraph0029;0030

[2]Brennauer,Albert;Keller,Max;Freund,Matthias;Bernhardt,Günther;Buschauer,Armin[TetrahedronLetters,2007,vol.48,#39,p.6996-6999]

[3]Svahn;Merenyi;Karlson;Widlund;Graells[JournalofMedicinalChemistry,1986,vol.29,#4,p.448-453]

[4]CurrentPatentAssignee:HINOVAPHARMACEUTICALS-EP3971176,2022,A1Locationinpatent:Paragraph0404-0405

[5]CurrentPatentAssignee:HINOVAPHARMACEUTICALS-EP3971176,2022,A1Locationinpatent:Paragraph0404-0405

[6]CurrentPatentAssignee:HINOVAPHARMACEUTICALS-EP3971176,2022,A1Locationinpatent:Paragraph0404-0405

[7]CurrentPatentAssignee:RESONACHOLDINGSCORPORATION-US5166403,1992,A

[8]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-EP727211,1996,A1

[9]Burns,DavidJ.;Lee,Ai-Lan;McLean,EuanB.;Mooney,DavidT.[OrganicLetters,2022,vol.24,#2,p.686-691]

[10]Kanuma,Kosuke;Omodera,Katsunori;Nishiguchi,Mariko;Funakoshi,Takeo;Chaki,Shigeyuki;Semple,Graeme;Tran,Thuy-Anh;Kramer,Bryan;Hsu,Debbie;Casper,Martin;Thomsen,Bill;Beeley,Nigel;Sekiguchi,Yoshinori[BioorganicandMedicinalChemistryLetters,2005,vol.15,#10,p.2565-2569]

[11]CurrentPatentAssignee:H.LUNDBECKA/S-US2007/213376,2007,A1Locationinpatent:Page/Pagecolumn10

[12]CurrentPatentAssignee:THEUNIVERSITYOFHONGKONG-WO2020/103891,2020,A1Locationinpatent:Page/Pagecolumn29;32-35

[13]Joossens;VanDerVeken;Lambeir;Augustyns;Haemers[JournalofMedicinalChemistry,2004,vol.47,#10,p.2411-2413]

[14]CurrentPatentAssignee:ASTRAZENECAPLC-US5914319,1999,A

[15]CurrentPatentAssignee:ASTRAZENECAPLC-US5705487,1998,A

[16]CurrentPatentAssignee:ASTRAZENECAPLC-US5710130,1998,A

[17]CurrentPatentAssignee:ASTRAZENECAPLC-US5707966,1998,A

[18]CurrentPatentAssignee:ASTRAZENECAPLC-US5726159,1998,A

[19]CurrentPatentAssignee:GPCRTHERAPEUTICSINC-US2006/281712,2006,A1Locationinpatent:Page/Pagecolumn122-124

[20]Jin,Fangfang;Hu,Qiyue;Fei,Hongbo;Lv,Hejun;Wang,Shenglan;Gui,Bin;Zhang,Junzhen;Tu,Wangyang;Zhang,Yun;Zhang,Lei;Wan,Hong;Zhang,Limin;Hu,Bin;Yang,Fanglong;Bai,Chang;He,Feng;Zhang,Lianshan;Tao,Weikang[ACSMedicinalChemistryLetters,2021,vol.12,#2,p.195-201]

[21]CurrentPatentAssignee:KUREHACORP.-EP1273571,2003,A1

[22]CurrentPatentAssignee:JIANGSUYANGNONGCHEMICALCO.,LTD.-CN114736168,2022,ALocationinpatent:Paragraph0101-0104

[23]CurrentPatentAssignee:ALTOSLABSINC-WO2022/212902,2022,A1Locationinpatent:Paragraph0335

[24]CurrentPatentAssignee:ALTOSLABSINC-WO2022/212902,2022,A1Locationinpatent:Paragraph0335

27687-14-5    50893-36-2   
4-(tert-Butoxycarbonylamino-methyl)-cyclohexanecarboxylicacid1-ethoxycarbonyloxy-ethylester 

[1]JournalofMedicinalChemistry,1986,vol.29,p.448-453

27687-14-5    98298-66-9   
4-(tert-Butoxycarbonylamino-methyl)-cyclohexanecarboxylicacid1-isopropoxycarbonyloxy-ethylester 

[1]JournalofMedicinalChemistry,1986,vol.29,p.448-453

27687-14-5    749866-15-7 

[1]Li,Liantao;Mayer,Matthias;Schneider,Erich;Schreiber,Elvira;Bernhardt,Guenther;Peng,Shiqi;Buschauer,Armin[ArchivderPharmazie,2003,vol.336,#12,p.585-590]

[2]CurrentPatentAssignee:GPCRTHERAPEUTICS-US2016/90394,2016,A1Locationinpatent:Paragraph0029;0031

[3]CurrentPatentAssignee:TESPHARMA-WO2020/104456,2020,A1Locationinpatent:Paragraph00546

Related Products of of 27687-14-5
1000933-99-2
1000933-99-2
1008773-73-6
1008773-73-6
1021919-45-8
1021919-45-8
1160247-17-5
1160247-17-5
115951-16-1
115951-16-1
1250996-75-8
1250996-75-8
Building Blocks More >
2785-89-9
2785-89-9
4-Ethyl-2-methoxyphenol
AA002UUR | MFCD00038714
29030-81-7
29030-81-7
Hexacosanoic acid, ethyl ester
AA002V6N
2854-32-2
2854-32-2
Ethanone, 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)-
AA002VL5 | MFCD01317813
286411-09-4
286411-09-4
1,8-Naphthyridin-4-ol, 7-chloro-2-phenyl-
AA002VUQ | MFCD03452891
287192-97-6
287192-97-6
tert-Butyl 4-ethynylpiperidine-1-carboxylate
AA002W6O | MFCD09038026
288067-35-6
288067-35-6
4-Bromo-2-hydroxybenzonitrile
AA002WHK | MFCD07780675
288627-94-1
288627-94-1
1-Hexyl-2,3-dimethylimidazolium iodide
AA002WT5 | MFCD18207720
2905-65-9
2905-65-9
methyl 3-chlorobenzoate
AA002X4M | MFCD00000592
29172-10-9
29172-10-9
Methyl 4-acetyl-5-methylfuran-2-carboxylate
AA002XI9 | MFCD00463178
292621-45-5
292621-45-5
4-Bromo-2-fluorobenzamide
AA002XSP | MFCD03094432
Historical Records
898344-67-7
898344-67-7
Submit
© 2017 AA BLOCKS, INC. All rights reserved.